Close

Professor Ian DOUGLAS

BSc MSc PhD

Professor
of Pharmacoepidemiology

Room
Room 248a

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
+44 (0)20 7927 2968

I am a pharmacoepidemiolgist and previouly studied physiology and completed a PhD in Manchester. Since then I have spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutcial industry investigating adverse effects of drugs - both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.

Affiliations

Faculty of Epidemiology and Population Health
Department of Non-communicable Disease Epidemiology

Teaching

I am Programme Director for the MSc in Epidmiology. I teach on the MSc as well as the LSHTM short courses in pharmacoepdemiology and pharmacovigilance.

Research

I'm interested in pharmacoepidemiology, and in particular, how we can use large linked electronic healthcare record databases to investigate the effects of drugs - both harmful and beneficial. I am exploring methodologies to minimise some of the biases inherent in the research of drug effects, and my main current areas of interest are case-only approaches to study design and how we can determine whether routine care data can be used to estimate the intended effects of medications.

Research Area
Drug discovery and development
Pharmacovigilance
Primary care
Public health
Electronic health records
Discipline
Pharmacoepidemiology
Epidemiology
Medicine
Pharmacology

Selected Publications

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017.
Wilkinson S; Douglas I; Stirnadel-Farrant H; Fogarty D; Pokrajac A; Smeeth L; Tomlinson L
2018
BMJ open
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK.
Bhaskaran K; Dos-Santos-Silva I; Leon DA; Douglas IJ; Smeeth L
2018
The lancet. Diabetes & endocrinology
Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015.
Sinnott SJ; Smeeth L; Williamson E; Douglas IJ
2017
BMJ (Clinical research ed)
Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort.
Yates TA; Tomlinson LA; Bhaskaran K; Langan S; Thomas S; Smeeth L; Douglas IJ
2017
PLoS medicine
Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.
Brauer R; Bhaskaran K; Chaturvedi N; Dexter DT; Smeeth L; Douglas I
2015
PLoS medicine
Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults.
Bhaskaran K; Douglas I; Forbes H; dos-Santos-Silva I; Leon DA; Smeeth L
2014
Lancet
Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs.
Douglas IJ; Evans SJ; Hingorani AD; Grosso AM; Timmis A; Hemingway H; Smeeth L
2012
BMJ (Clinical research ed)
See more Publications